Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Glutathione S-transferase P–c-Jun N-terminal kinase (GSTP1-JNK) complex is a critical regulatory protein assembly that modulates cellular responses to oxidative stress and apoptotic stimuli. Under basal conditions, the GSTP1-1 homodimer binds directly to the C-terminus of c-Jun N-terminal kinase (JNK), sequestering it in an inactive state and preventing the activation of the pro-apoptotic MAPK signaling pathway (Adler et al., 1999, EMBO J). In response to oxidative stress or specific pharmacological triggers, the complex dissociates, allowing JNK to become phosphorylated and initiate downstream signaling leading to cell death or differentiation (Laborde, 2010, Antioxidants & Redox Signaling). This complex is frequently exploited by cancer cells, where GSTP1 is overexpressed to suppress JNK-mediated apoptosis, thereby contributing to multi-drug resistance (Townsend et al., 2009, Cancer Research). Therapeutic strategies targeting this complex often involve small molecule inhibitors or glutathione analogs, such as Ezatiostat (TLK199), that disrupt the interaction to effectively 'release' JNK and promote apoptosis in malignant cells or stimulate hematopoiesis in conditions like myelodysplastic syndrome (Ruscoe et al., 2001, JPET). As such, the GSTP1-JNK complex represents a significant target for overcoming chemoresistance and modulating stress-activated protein kinase pathways.
Disruption of the protein-protein interaction to release and activate JNK-mediated apoptotic signaling.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione S-transferase P–c-Jun N-terminal kinase complex (GSTP1-JNK complex) (GSTP1-JNK complex).